Powder: -20°C for 3 years
In solvent: -80°C for 2 years
Bremelanotide is an agonist of Melanocortin Receptor (MCR) .
Description | Bremelanotide is an agonist of melanocortin receptor (MCR) . |
In vivo | Treatment with Bremelanotide?(100 or 200 μg/kg) significantly increased proceptive solicitations in females primed with E+Por E alone (E+O) in bilevel chambers[1] |
Animal Research | Bremelanotide(PT-141), a cyclic heptapeptide melanocortin analogue (Palatin Technologies, Cranbury, NJ), was dissolved in saline to obtain doses of 50, 100, and 200 μg/kg/ml, and injected s.c. 5 min before each behavioral test. An equal volume of saline was administered to control animals[1]. |
Synonyms | bremelanotide, PT-141 Acetate |
Molecular Weight | 1085.22 |
Formula | C52H72N14O12 |
CAS No. | 1607799-13-2 |
Powder: -20°C for 3 years
In solvent: -80°C for 2 years
DMSO: 36 mg/mL (33.17 mM)
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Bremelanotide Acetate 1607799-13-2 GPCR/G Protein Neuroscience Melanocortin Receptor inhibit PT141 bremelanotide MC Receptor PT 141 Inhibitor PT-141 PT-141 Acetate inhibitor